While RB1 remains the primary gene associated with retinoblastoma, and MYCN amplification accounts for a small subset of non-hereditary, unilateral cases, emerging research has identified a number of additional genes that may play a role in retinoblastoma development or progression. This evidence concerns the gene MYCN and retinoblastoma.